Fig. 6From: A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinomaRole of risk scores in immune infiltration and immunotherapy response. AÂ The relationship between the risk score and multiple infiltrating immune cells. BÂ The relationship between the risk score and multiple inflammatory factors and immune checkpoints. CÂ TIDE scores in the high-risk and low-risk groups. DÂ Comparison of TMB levels between the high-risk group and the low-risk group. (* p Ë‚ 0.05, ** p Ë‚ 0.01, *** p Ë‚ 0.001)Back to article page